Skip to main content

Table 1 Baseline characteristics

From: Patient-centered Pharmacist Care in the Hemodialysis Unit: a quasi-experimental interrupted time series study

Baseline characteristics a

Patients (n = 72)

Patient factors

 Age (years)

59 (47–67.5)

 Sex (male)

38 (52.8)

 Body mass index (kg/m2)

24.8 (21.7–29.8)

 Educational level

  Illiterate

30 (41.7)

  Preparatory school and below

25 (34.7)

  High school and above

17 (23.6)

 Marital status (married) 

55 (76.4)

 Employed 

12 (16.7)

 Smokingb

7 (9.7)

 Caregiver

24 (33.3)

Clinical factors

 Longevity on dialysis (> 5 years)

31 (43)

 Recent hospitalization

8 (11.1)

 Diabetes

38 (52.8)

 Hypertension

65 (90.3)

 Ischemic heart disease

16 (22.2)

 Heart failurec

4 (5.6)

 Cerebrovascular infarction

10 (13.9)

 Peripheral vascular diseasec

9 (12.5)

 Atrial fibrillation

5 (6.9)

 Dementia

2 (2.8)

 Previous history of kidney transplant

2 (2.8)

 Hepatitis B

4 (5.6)

 Hepatitis C

8 (11.1)

 Parathyroid adenoma

7 (10%)

Dialysis-related factors

 Access of dialysis: arteriovenous fistula

33 (45.8)

 Adequacy of dialysis: (Kt/V) c

1.58 ± 0.33

 Intra-dialytic weight gain to dry body weight percentage

3.4 (2.5–5)

 Pre-dialysis phosphate (mmol/L)

1.45 (1.5–1.8)

 Intact parathyroid hormone (pg/mL)

545 (361–1236)

Medication-related factors

 Total pill burden (electronic records)

11.3 ± 5.5

 Daily tablet count (self-reported)

7 (5–11)

 Number of medications per patient (electronic records)

7 (5–8)

  1. Values are given as n (%), mean ± standard deviation, or median (interquartile range). a All baseline characteristics were measured in the first month of the study except for the adequacy of dialysis, which is the mean of the first three months. All baseline characteristics were based on the documentation in EHRs and patients’ self-reports. b Smoking: the data for one patient was missing.c As reported in the electronic healthcare records. Kt/V: a measure for assessing the adequacy of dialysis based on the clearance of urea during dialysis